Literature DB >> 8763876

Radiation sensitisation by nitric oxide releasing agents.

J B Mitchell1, J A Cook, M C Krishna, W DeGraff, J Gamson, J Fisher, D Christodoulou, D A Wink.   

Abstract

Previous studies have shown that nitric oxide (NO) sensitises hypoxic cells to ionising radiation. In the present study, four different nitric oxide (NO) donor agents were evaluated for both NO release and hypoxic radiosensitisation. The S-nitrosothiol NO donor agents, S-nitrosoglutathione (GSNO) and S-nitroso-N-acetylpenicillamine (SNAP), were shown to release sustained NO concentrations (microM) and significantly radiosensitise hypoxic cells. The extent of hypoxic radiosensitisation by both of these agents at 1.0 mM concentration was similar to that obtained with molecular oxygen. In contrast, neither 3-morpholinosydnonimine (SIN-1) nor sodium nitroprusside (SNP) released detectable NO concentrations and neither agent enhanced the hypoxic radiation response to the extent of that observed for GSNO or SNAP. NO-mediated hypoxic cell radiosensitisation by NO donor drugs may offer a new approach for clinical consideration, particularly if such agents can be selectively delivered to hypoxic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763876      PMCID: PMC2149980     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  14 in total

1.  Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects.

Authors:  C M Maragos; D Morley; D A Wink; T M Dunams; J E Saavedra; A Hoffman; A A Bove; L Isaac; J A Hrabie; L K Keefer
Journal:  J Med Chem       Date:  1991-11       Impact factor: 7.446

Review 2.  Biosynthesis and metabolism of endothelium-derived nitric oxide.

Authors:  L J Ignarro
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

3.  Computer programs for the analysis of cellular survival data.

Authors:  N Albright
Journal:  Radiat Res       Date:  1987-11       Impact factor: 2.841

4.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

Authors:  L J Ignarro; H Lippton; J C Edwards; W H Baricos; A L Hyman; P J Kadowitz; C A Gruetter
Journal:  J Pharmacol Exp Ther       Date:  1981-09       Impact factor: 4.030

5.  Potentiation of cellular radiosensitivity by nitroprusside and vitamin B12.

Authors:  E B Douple; C J Green; M G Simic
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-11       Impact factor: 7.038

6.  Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species.

Authors:  D A Wink; I Hanbauer; M C Krishna; W DeGraff; J Gamson; J B Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Hypoxic mammalian cell radiosensitization by nitric oxide.

Authors:  J B Mitchell; D A Wink; W DeGraff; J Gamson; L K Keefer; M C Krishna
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

8.  In vivo radiation protection by nitric oxide modulation.

Authors:  J Liebmann; A M DeLuca; D Coffin; L K Keefer; D Venzon; D A Wink; J B Mitchell
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

9.  On the mechanism of NO release from sydnonimines.

Authors:  M Feelisch; J Ostrowski; E Noack
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

10.  Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability.

Authors:  P J Wood; I J Stratford; G E Adams; C Szabo; C Thiemermann; J R Vane
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

View more
  12 in total

1.  Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.

Authors:  Astrid Weyerbrock; Stuart Walbridge; Joseph E Saavedra; Larry K Keefer; Edward H Oldfield
Journal:  Neuro Oncol       Date:  2010-11-01       Impact factor: 12.300

2.  CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production.

Authors:  Xiaoli Li; Dan Liu; Xin Liu; Weiwei Jiang; Weiying Zhou; Wei Yan; Yanyan Cen; Bin Li; Guanqun Cao; Guofu Ding; Xueli Pang; Jianguo Sun; Jiang Zheng; Hong Zhou
Journal:  Tumour Biol       Date:  2012-06-28

3.  Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents.

Authors:  M Kurimoto; S Endo; Y Hirashima; H Hamada; T Ogiichi; A Takaku
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

Review 4.  Signaling and stress: The redox landscape in NOS2 biology.

Authors:  Douglas D Thomas; Julie L Heinecke; Lisa A Ridnour; Robert Y Cheng; Aparna H Kesarwala; Christopher H Switzer; Daniel W McVicar; David D Roberts; Sharon Glynn; Jon M Fukuto; David A Wink; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2015-06-24       Impact factor: 7.376

5.  JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.

Authors:  Astrid Weyerbrock; Nadja Osterberg; Nikolaos Psarras; Brunhilde Baumer; Evangelos Kogias; Anna Werres; Stefanie Bette; Joseph E Saavedra; Larry K Keefer; Anna Papazoglou
Journal:  Neurosurgery       Date:  2012-02       Impact factor: 4.654

6.  Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.

Authors:  Debashree Basudhar; Robert C Cheng; Gaurav Bharadwaj; Lisa A Ridnour; David A Wink; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2015-02-04       Impact factor: 7.376

7.  Suberoylanilide hydroxamic acid radiosensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide.

Authors:  Yuval Samuni; David A Wink; Murali C Krishna; James B Mitchell; Sara Goldstein
Journal:  Free Radic Biol Med       Date:  2014-05-28       Impact factor: 7.376

8.  Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase.

Authors:  D L Berge; M De Ridder; V N Verovski; M Y Janssens; C Monsaert; G A Storme
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

9.  Radiation enhances the therapeutic effect of Banoxantrone in hypoxic tumour cells with elevated levels of nitric oxide synthase.

Authors:  Manal Mehibel; Simendra Singh; Rachel L Cowen; Kaye J Williams; Ian J Stratford
Journal:  Oncol Rep       Date:  2016-01-13       Impact factor: 3.906

10.  Cebpd Is Essential for Gamma-Tocotrienol Mediated Protection against Radiation-Induced Hematopoietic and Intestinal Injury.

Authors:  Sudip Banerjee; Sumit K Shah; Stepan B Melnyk; Rupak Pathak; Martin Hauer-Jensen; Snehalata A Pawar
Journal:  Antioxidants (Basel)       Date:  2018-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.